GlassScriptPhysician profile
Angela Rogers
NPI 1871960948
$5,042.28
in general payments reported to CMS, 2019-2025
50 companies · $933 in 2025
The $933 reported for 2025 was more than what 86% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $969 · 2022: $976 · 2023: $856 · 2024: $1,308 · 2025: $933.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,074 · Education: $22.58.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,074.39 |
| Education | $22.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $824.46 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $677.18 | 2021-2025 | Tepezza, Repatha, Evenity |
| Lilly USA, LLC | $404.45 | 2021-2024 | Jardiance, Baqsimi, Lyumjev |
| Insulet Corporation | $307.02 | 2021-2025 | Omnipod |
| Corcept Therapeutics | $291.66 | 2024-2025 | Korlym |
| Shield Therapeutics INC | $185.20 | 2023-2024 | Accrufer |
| Novartis Pharmaceuticals Corporation | $176.96 | 2021-2025 | |
| Abbott Laboratories | $174.50 | 2021-2022 | |
| Abbvie INC. | $171.96 | 2021-2024 | |
| Sanofi-Aventis U.S. LLC | $163.18 | 2022-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $138.68 | 2021-2025 | Jardiance |
| Janssen Pharmaceuticals, INC | $136.47 | 2021-2023 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $133.98 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $76.10 | 2023-2025 | |
| Tandem Diabetes Care, INC. | $73.40 | 2023-2024 | T:Slim X2 Insulin Pump With Control-Iq |
Show all 50 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angela Rogers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.